News on molecular diagnostics, pharmacogenomics tests for coronary artery disease, congenital heart defects, and more.
UK's NICE Recommends Genetic Testing for Therapy Selection in Stroke Patients
Clopidogrel is less effective at preventing subsequent strokes in patients with certain variations in the CYP2C19 gene and testing could aid treatment selection.
Illumina, Henry Ford Health Partner on Genomic Testing for Cardiovascular Patients
The partnership could yield data to support the use of whole-genome sequencing in treating and managing cardiovascular disease, the leading cause of death in the US.
Cardio Diagnostics Enters Private Financing Agreement for up to $11.2M
The firm intends to use the proceeds to accelerate the adoption of its PrecisionCHD and Epi+Gen CHD tests and to launch additional tests.
QuidelOrtho Gets Canadian Approval for Point-of-Care High-Sensitivity Troponin Test
The immunoassay detects a subunit of the troponin complex released by heart muscle cells after a myocardial infarction.
The firm uses epigenetic and genetic information, along with machine learning to determine a patient's risk of cardiovascular disease.